Advances in systolic heart failure

Heart failure due to systolic dysfunction has enormous global impact. Medical management based on an understanding of the pathophysiology of the disease as well as its neurohormonal mechanisms has greatly advanced over the past 25 years. Below is a review of recent and emerging data on epidemiology...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuzefpolskaya, Melana, Weinberg, Catherine, Kukin, Marrick
Formato: Texto
Lenguaje:English
Publicado: Medicine Reports 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948383/
https://www.ncbi.nlm.nih.gov/pubmed/20948854
http://dx.doi.org/10.3410/M2-31
_version_ 1782187458717286400
author Yuzefpolskaya, Melana
Weinberg, Catherine
Kukin, Marrick
author_facet Yuzefpolskaya, Melana
Weinberg, Catherine
Kukin, Marrick
author_sort Yuzefpolskaya, Melana
collection PubMed
description Heart failure due to systolic dysfunction has enormous global impact. Medical management based on an understanding of the pathophysiology of the disease as well as its neurohormonal mechanisms has greatly advanced over the past 25 years. Below is a review of recent and emerging data on epidemiology and diagnosis of heart failure due to systolic dysfunction and the current and future management techniques to ameliorate this disease. At the end, we will highlight three significant trials in the field in 2009 that will impact heart failure care: STICH, MADIT-CRT, and HeartMate II.
format Text
id pubmed-2948383
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medicine Reports
record_format MEDLINE/PubMed
spelling pubmed-29483832010-10-14 Advances in systolic heart failure Yuzefpolskaya, Melana Weinberg, Catherine Kukin, Marrick F1000 Med Rep Review Article Heart failure due to systolic dysfunction has enormous global impact. Medical management based on an understanding of the pathophysiology of the disease as well as its neurohormonal mechanisms has greatly advanced over the past 25 years. Below is a review of recent and emerging data on epidemiology and diagnosis of heart failure due to systolic dysfunction and the current and future management techniques to ameliorate this disease. At the end, we will highlight three significant trials in the field in 2009 that will impact heart failure care: STICH, MADIT-CRT, and HeartMate II. Medicine Reports 2010-04-27 /pmc/articles/PMC2948383/ /pubmed/20948854 http://dx.doi.org/10.3410/M2-31 Text en © 2010 Medicine Reports Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Yuzefpolskaya, Melana
Weinberg, Catherine
Kukin, Marrick
Advances in systolic heart failure
title Advances in systolic heart failure
title_full Advances in systolic heart failure
title_fullStr Advances in systolic heart failure
title_full_unstemmed Advances in systolic heart failure
title_short Advances in systolic heart failure
title_sort advances in systolic heart failure
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948383/
https://www.ncbi.nlm.nih.gov/pubmed/20948854
http://dx.doi.org/10.3410/M2-31
work_keys_str_mv AT yuzefpolskayamelana advancesinsystolicheartfailure
AT weinbergcatherine advancesinsystolicheartfailure
AT kukinmarrick advancesinsystolicheartfailure

Ejemplares similares